JHX – UBS rates the stock as Buy

James Hardie’s September-quarter profit beat UBS by 6% and the FY22 profit guidance range has been raised by 4% at the midpoint, on the back of 9% growth in North America.

The company is still targeting a longer term mix of 66% of high-value product in the region. The broker believes substitution will slow over time but agrees with the strategy of targeting not just high-value but high-quality leads.

James Hardie is also “prudently” adding capacity in all of North America, Europe and Asia-Pacific. Target rises to $59.80 from $54.70, Buy retained.

Sector: Materials.

 

Target price is $59.80.Current Price is $54.77. Difference: $5.03 – (brackets indicate current price is over target). If JHX meets the UBS target it will return approximately 8% (excluding dividends, fees and charges – negative figures indicate an expected loss).

 

 

About Broker News

FNArena's Australian Broker Call, is your daily news report on the latest recommendation, valuation, forecast and opinions recently published by Stockbrokers.

View more articles by Broker News →